Schedule 13D ownership disclosure
PetLife Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 71639B105
Event date: 2014-11-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,491,944
- Percent of class
- 9.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001360865-15-000011
- Form type
- SC 13D
- Filer
- PetLife Pharmaceuticals, Inc.
- CIK
- CIK 1354591
- Filed
- May 15, 2015
- Reporting period
- Nov 14, 2014
- Description
- Schedule 13D beneficial ownership